Keynote:
Drug and target discovery with explainable AI.
Abstract:
- What is “explainable” artificial intelligence? An intro for scientists and researchers.
- Why is “explainability” necessary for pharma and life science?
- An RNA therapeutics use case: Applying explainable AI to augment understanding.
- The future: How to harness the power of explainable AI to reshape drug development.
You can download this presentation.
You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.
Event overview:
RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious and chronic diseases. This is reflected with the value of the global antisense & RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%. With Covid-19 rapidly accelerating the RNA landscape through massive regulatory successes, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, there has been considerable progress in the development of RNA medicines and a major expansion of the RNA-therapeutics field.
